Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.415
-0.045 (-3.08%)
Jul 15, 2025, 1:17 PM - Market open
Erasca Market Cap
Erasca has a market cap or net worth of $400.85 million as of July 15, 2025. Its market cap has decreased by -29.30% in one year.
Market Cap
400.85M
Enterprise Value
39.17M
1-Year Change
-29.30%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $400.85M, a decrease of -78.43%. That is a compound annual growth rate of -31.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 410.77M | -42.12% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |